Product
Supplier
Encyclopedia
Inquiry
Home > News > Food Industry News > Vitamin C deployed in big doses to help treat coronavirus patients

Vitamin C deployed in big doses to help treat coronavirus patients

SCMP 2020-04-09

Hospitals in the United States and China administer the supplement as part of a therapy for people with Covid-19.


Vitamin C is often suggested as a dietary supplement for people who have caught a cold, but is not considered a cure for diseases like influenza.
A similar treatment is also being tested in Wuhan, the central Chinese city where the coronavirus was first detected.


Professor Liu Shi of Wuhan Union Hospital, said the medical centre, which has a large number of Covid-19 patients with severe symptoms, had also tried the therapy.


“It was also administered to the patients intravenously, along with other drugs, because they are all seriously ill,” she said.


“We still don’t know whether this helps [their] recovery – this needs a lot of research,” she said, adding that unlike vitamins A and D, Vitamin C is not toxic even if consumed in high doses because it is water soluble and therefore can be excreted easily.


Professor Yang Jinkui, from Beijing Tongren Hospital, said there was no scientific evidence to support the use of Vitamin C and any suggestion that it could be an effective cure was “completely groundless”.


“In my understanding, it may be serving as a placebo as there is no special drug for this new disease yet. Sometimes it is deception with good intentions,” Yang said.


“[People] in different countries may have different fixations with some particular therapies, just like we [Chinese people] prefer herbal medicine.”
Wang Xiaogang, a doctor at Beijing Hospital, who has treated seriously ill coronavirus patients in Wuhan, agreed that there was no clinical evidence to prove that Vitamin C really helped.


“This is meaningless,” Wang said.


Scientific studies to date only suggested that Vitamin C might have an effect in the treatment of cancer, cardiovascular disease, age-related macular degeneration and the common cold, according to the NIH.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.